Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23416,85,0.97 [0.79-1.18],0.735535576234659
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23910,126,0.98 [0.86-1.13],0.8266145722897064
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23702,871,1.04 [0.99-1.09],0.1096738725849066
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23934,254,0.93 [0.83-1.03],0.1725786991443137
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23251,2368,1.01 [0.98-1.04],0.5168693880409808
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23475,1793,1.02 [0.99-1.06],0.2301176889334484
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23762,860,1.00 [0.95-1.05],0.9043124426826182
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23868,37,0.92 [0.69-1.24],0.5998225278435865
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22836,555,1.02 [0.96-1.09],0.5430776483734092
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,22065,527,1.04 [0.98-1.11],0.1909177287204856
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22281,146,0.94 [0.80-1.09],0.3900556749551345
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17776,1044,1.03 [0.98-1.09],0.2116812722776843
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,22085,249,1.08 [0.99-1.17],0.0980084008880806
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23902,1000,1.00 [0.95-1.04],0.8961865731656469
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Mycoses,23991,311,0.97 [0.88-1.06],0.4573275125338516
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23359,528,1.06 [1.00-1.12],0.0509735706102
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23940,609,1.02 [0.96-1.09],0.4945132978717249
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,23030,128,0.99 [0.86-1.14],0.8798388315735217
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,24034,26,0.97 [0.69-1.38],0.885051993690676
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23867,536,1.02 [0.95-1.09],0.6221882623540624
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23894,63,0.93 [0.75-1.15],0.4841505790888966
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23946,151,1.00 [0.90-1.10],0.9440544554006448
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23931,136,0.99 [0.89-1.11],0.8970798133968277
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,23129,298,0.99 [0.89-1.09],0.7714490647298011
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,23036,205,1.01 [0.91-1.11],0.9086020085194608
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22966,64,1.01 [0.83-1.22],0.953190339150656
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,24009,46,0.94 [0.72-1.23],0.6390474229065877
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23979,115,0.96 [0.83-1.10],0.5406279042308771
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral warts,23903,39,1.03 [0.83-1.27],0.8191856599909961
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23909,45,0.81 [0.60-1.09],0.1707790858254547
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm,23776,275,1.03 [0.95-1.13],0.4267153151964608
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23956,63,1.08 [0.93-1.25],0.2994170942523088
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23933,68,1.09 [0.94-1.26],0.2356036058537159
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10715,35,1.19 [0.64-2.22],0.5841080745674105
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23854,1011,1.04 [0.99-1.09],0.1152163903404055
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of meninges,24022,41,0.95 [0.75-1.19],0.6354937630594296
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24004,44,1.13 [0.94-1.36],0.1791005196291462
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,24012,79,1.12 [0.98-1.27],0.1014862777974525
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of ovary,13262,83,0.97 [0.85-1.09],0.5718012737641975
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,24026,235,1.07 [0.96-1.18],0.2295120927800515
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Caecum,24023,178,0.98 [0.85-1.11],0.7155020675017294
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23967,47,1.00 [0.80-1.26],0.9977224514306337
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Descending colon,24029,153,1.22 [1.09-1.35],0.0002597930831702
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Rectum,23995,249,1.10 [1.01-1.20],0.0260280827848365
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23963,478,1.01 [0.94-1.09],0.6923186678900801
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,24026,266,1.10 [1.00-1.21],0.0408265117507147
RLN2,Prorelaxin H2,Chapter II Neoplasms,Carcinoma in situ of breast,11368,76,1.00 [0.88-1.14],0.9996833363833882
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",11405,84,1.00 [0.89-1.13],0.9563427554227412
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",20733,30,1.16 [0.90-1.48],0.2446176834833394
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",20738,35,0.95 [0.70-1.30],0.7491591646104045
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23996,94,0.96 [0.83-1.12],0.6292498618531268
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Haemangioma, any site",23996,92,0.97 [0.83-1.12],0.6620271059559966
RLN2,Prorelaxin H2,Chapter II Neoplasms,Leiomyoma of uterus,12696,353,1.08 [1.03-1.12],0.0003889690834422
RLN2,Prorelaxin H2,Chapter II Neoplasms,Lung cancer and mesothelioma,17796,158,1.03 [0.90-1.19],0.6494858200478845
RLN2,Prorelaxin H2,Chapter II Neoplasms,Lymphoid leukaemia,20730,27,1.11 [0.85-1.44],0.446090014373573
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20827,124,1.03 [0.92-1.15],0.5869059418420124
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",20781,78,0.86 [0.65-1.13],0.2793787132802923
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",11453,67,1.12 [0.99-1.26],0.0721707389072893
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",20746,43,1.07 [0.84-1.37],0.5997847105967584
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",20757,54,1.12 [0.94-1.35],0.2047859105607833
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",20768,65,0.88 [0.59-1.30],0.5088613197273526
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",11434,48,0.89 [0.72-1.10],0.2715019137242316
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",20754,51,0.90 [0.68-1.18],0.4330199099195557
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9657,340,1.30 [1.07-1.58],0.00969240113066
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",20784,81,0.97 [0.78-1.21],0.7753096558835396
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",20751,48,0.81 [0.54-1.21],0.3061309952421547
RLN2,Prorelaxin H2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,20758,55,1.06 [0.89-1.27],0.5195446839974872
RLN2,Prorelaxin H2,Chapter II Neoplasms,Melanocytic naevi,23829,188,1.02 [0.94-1.11],0.5602649577258942
RLN2,Prorelaxin H2,Chapter II Neoplasms,Melanocytic naevi of trunk,23992,86,1.11 [0.99-1.25],0.0762350953205255
RLN2,Prorelaxin H2,Chapter II Neoplasms,Melanoma in situ,20714,40,1.10 [0.90-1.34],0.3413731669994044
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",20759,56,0.98 [0.79-1.23],0.8793034688634814
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20806,103,1.01 [0.86-1.18],0.9073015344388168
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",20808,105,1.04 [0.88-1.23],0.6458264616067633
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",20762,59,1.01 [0.84-1.23],0.9015705533484112
RLN2,Prorelaxin H2,Chapter II Neoplasms,Other benign neoplasms of skin,23875,129,1.07 [0.97-1.18],0.1863208267565813
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21265,562,1.00 [0.94-1.07],0.8853818165628682
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21294,591,1.02 [0.96-1.09],0.5184276560883937
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23789,256,1.00 [0.91-1.09],0.9485148263852068
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22803,41,1.19 [0.96-1.47],0.1169667793394669
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23598,65,1.10 [0.95-1.27],0.19815265526822
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23334,1934,1.04 [1.01-1.07],0.0135161342658352
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,23012,19,1.05 [0.67-1.65],0.8286653061502806
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23722,29,1.11 [0.91-1.36],0.3041401300560042
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23644,882,1.05 [1.01-1.10],0.0265973994353212
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23644,882,1.05 [1.01-1.10],0.0265973994353212
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22811,49,0.99 [0.81-1.22],0.9318842578674452
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23787,794,1.03 [0.99-1.08],0.1510451314805391
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23787,94,1.03 [0.89-1.18],0.7180954276663957
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23578,45,0.74 [0.49-1.10],0.1337960020087086
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23571,38,1.14 [0.95-1.36],0.153489037690475
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23866,173,0.99 [0.88-1.11],0.8588626085570326
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23964,60,1.00 [0.85-1.17],0.9899304716835012
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23842,149,0.95 [0.83-1.09],0.4803938266614318
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,23057,64,1.08 [0.94-1.24],0.2831509172613025
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,20626,177,0.98 [0.86-1.12],0.8194946823220998
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22341,106,0.96 [0.81-1.14],0.6722755293059521
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22362,127,1.02 [0.88-1.18],0.8325793631904066
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,20482,33,0.99 [0.74-1.33],0.9565281118095582
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22298,64,0.90 [0.71-1.13],0.3578373689176011
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21980,124,1.01 [0.90-1.14],0.806717336201932
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23905,144,1.03 [0.88-1.21],0.6846984738140157
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23808,47,1.12 [0.94-1.35],0.2123731604083742
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23793,32,0.64 [0.34-1.19],0.1580938466780262
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23679,1445,0.98 [0.94-1.01],0.2139081132863601
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21513,1404,0.97 [0.94-1.01],0.1534751782369939
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",20486,37,1.08 [0.85-1.37],0.5447416021387841
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22599,52,0.91 [0.71-1.15],0.4137789537351917
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,20608,159,1.04 [0.92-1.16],0.5511479905706991
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,20504,55,1.01 [0.81-1.26],0.9184577521610362
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22529,2080,0.99 [0.95-1.03],0.704184950477817
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,20554,105,0.92 [0.77-1.11],0.4109156844145067
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,20789,340,1.01 [0.92-1.10],0.8638130051057737
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23948,226,1.04 [0.96-1.13],0.3343678509847103
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23812,90,1.07 [0.94-1.22],0.3032167353991764
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,20538,89,1.01 [0.85-1.21],0.9084333979689392
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20484,35,1.12 [0.90-1.40],0.3187088282551746
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23660,1113,0.99 [0.95-1.03],0.5222715039325597
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,20562,113,1.13 [0.99-1.29],0.06335455640395
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,20583,134,1.11 [0.96-1.27],0.1486747788678913
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20786,337,1.03 [0.94-1.14],0.5111483274275912
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,20504,55,1.07 [0.86-1.33],0.5255386875298258
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23807,85,1.08 [0.95-1.24],0.2337353209071328
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,20715,266,0.91 [0.80-1.03],0.133496583765613
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,20718,269,1.05 [0.96-1.14],0.2778441392898257
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21908,52,0.96 [0.78-1.18],0.7082957306903888
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23426,2977,0.99 [0.96-1.03],0.7320612004969538
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22574,27,0.86 [0.67-1.11],0.2375965373786075
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22599,52,0.95 [0.79-1.14],0.5718056204754686
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23873,1699,0.99 [0.95-1.02],0.4711757461203335
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23875,1695,0.99 [0.95-1.02],0.4842245546006124
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22579,32,0.98 [0.80-1.21],0.8547159123766332
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23756,1083,0.98 [0.94-1.02],0.3936504729906691
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21235,786,1.01 [0.96-1.07],0.6951884229062537
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,24025,111,0.89 [0.75-1.07],0.2299747400141714
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23791,30,0.97 [0.67-1.39],0.8590375018698804
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22751,78,1.03 [0.90-1.17],0.7022319900772334
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22770,97,1.02 [0.90-1.17],0.7268604439546474
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",20559,110,1.02 [0.89-1.15],0.8095348503190549
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22461,107,1.00 [0.84-1.18],0.9732486807171524
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1500,60,0.93 [0.66-1.30],0.6650537768164315
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1594,165,0.98 [0.83-1.15],0.7785772421119203
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22391,37,0.97 [0.65-1.45],0.8707038413716348
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1472,32,1.02 [0.72-1.43],0.9120579024904754
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23676,1322,1.01 [0.96-1.06],0.7189044987716758
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23821,60,1.17 [0.97-1.41],0.1057920872130827
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22097,241,0.99 [0.91-1.08],0.8528236966758872
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20807,358,1.00 [0.92-1.09],0.9638047423110914
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23955,151,0.95 [0.83-1.09],0.4808230677396418
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23370,47,1.13 [0.84-1.52],0.4339624126510931
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Angina pectoris,22932,695,1.05 [0.98-1.12],0.1475541829011417
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23416,93,1.06 [0.85-1.32],0.6015578945627478
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23351,28,0.70 [0.35-1.40],0.3109065184604331
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23418,95,0.92 [0.73-1.16],0.4814463079579726
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17083,808,0.99 [0.92-1.07],0.7524604235286916
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,AV-block,21859,158,0.90 [0.73-1.11],0.3247443713297583
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24005,228,1.00 [0.89-1.11],0.9346839637183296
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Cardiac arrest,16369,94,0.92 [0.73-1.16],0.4720074449327344
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21818,117,0.95 [0.79-1.13],0.5421027598883175
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",21774,73,0.96 [0.77-1.19],0.6897738714167888
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,24036,15,1.19 [0.89-1.58],0.2478649320682701
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Conduction disorders,22170,469,0.96 [0.87-1.06],0.4263065068242267
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23394,1166,1.00 [0.94-1.06],0.9592815576881344
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22325,5280,1.00 [0.98-1.03],0.7655554195347171
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,23035,160,0.97 [0.85-1.10],0.6041197037898878
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Endocarditis,21742,41,1.10 [0.87-1.40],0.4315855888655331
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23928,456,0.96 [0.87-1.05],0.3629374802960251
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Hypertension,22815,4296,1.01 [0.99-1.04],0.2918423827994945
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22824,4305,1.01 [0.99-1.04],0.2457435564717405
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23879,50,0.80 [0.52-1.23],0.3064966379081161
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18600,81,1.13 [0.98-1.31],0.0909192467484031
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18560,41,1.21 [1.00-1.46],0.0559139880318958
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Hypotension,23946,599,1.01 [0.95-1.08],0.6520325745007435
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23576,58,0.75 [0.51-1.11],0.1459491746784654
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23540,1303,1.00 [0.95-1.05],0.9861684954956664
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23842,273,0.97 [0.86-1.09],0.6059331051071917
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,21884,183,0.88 [0.74-1.05],0.1652632380130937
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23812,524,0.96 [0.87-1.05],0.3370084317773317
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22665,428,0.97 [0.87-1.07],0.516756014282638
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23986,106,1.01 [0.81-1.26],0.9414724751861572
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",24021,182,0.91 [0.77-1.07],0.2531033698840893
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Oesophageal varices,22906,31,1.13 [0.87-1.47],0.3508602893715623
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other aneurysm,23364,41,0.96 [0.75-1.23],0.7482613358048381
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other arrhythmias,21924,223,1.04 [0.94-1.15],0.4598728953239903
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23382,59,0.84 [0.59-1.20],0.3333862418831948
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23449,126,1.11 [0.99-1.24],0.0662151384605344
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21814,113,0.98 [0.84-1.13],0.7449310479633455
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other disorders of veins,22938,63,0.93 [0.74-1.16],0.5021154010369713
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22920,45,1.03 [0.84-1.26],0.7604673001974084
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23356,33,1.04 [0.71-1.50],0.8537241241139422
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22957,82,0.97 [0.83-1.14],0.7113679364282799
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22217,516,1.03 [0.96-1.12],0.3880769058016143
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23389,42,0.98 [0.73-1.31],0.8782582115686217
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23634,311,1.02 [0.94-1.10],0.6777778296295395
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23642,139,1.08 [0.95-1.22],0.2290351881574724
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23531,208,0.88 [0.75-1.04],0.1382766906639272
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16490,215,0.99 [0.88-1.11],0.8494280311205034
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23486,185,1.03 [0.91-1.17],0.615859339552445
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),23092,217,0.99 [0.88-1.10],0.8036611821507443
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23795,292,1.02 [0.93-1.13],0.6285504869902628
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23998,277,0.97 [0.86-1.08],0.5459502221863415
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,21852,151,1.08 [0.95-1.24],0.2396178449766162
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23639,136,1.09 [0.96-1.24],0.1641941505398166
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23427,104,0.99 [0.82-1.18],0.8826615893623995
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23837,319,0.93 [0.82-1.05],0.2265972258914813
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23814,351,0.94 [0.85-1.05],0.3037006505609709
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23553,48,0.96 [0.75-1.23],0.76642416988496
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23372,50,0.93 [0.65-1.32],0.682337693591895
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23683,114,1.07 [0.93-1.22],0.3317982586510212
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23441,153,0.88 [0.72-1.07],0.1996558836060994
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Varicose veins,23140,265,1.03 [0.94-1.12],0.5122489388481055
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23333,44,1.01 [0.80-1.27],0.9352884463672556
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23883,455,0.98 [0.90-1.06],0.6492428321374724
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23899,332,0.97 [0.87-1.07],0.4821602238656423
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21394,1241,0.99 [0.95-1.02],0.4501316278832586
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Any mental disorder,23379,3226,0.98 [0.96-1.01],0.1227106882992727
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23847,387,0.96 [0.88-1.06],0.4356569651787877
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21627,1474,0.97 [0.94-1.01],0.1343146364959449
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20225,72,1.09 [0.95-1.25],0.2288097719490031
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Smoking dependency,23556,1340,0.99 [0.95-1.03],0.5652530074120755
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21702,1549,0.98 [0.94-1.02],0.3229890207832994
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Vascular dementia,23936,18,1.01 [0.59-1.72],0.976424883683768
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Alzheimer disease,24035,64,1.03 [0.86-1.24],0.753607086876811
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Bell's palsy,22571,66,0.97 [0.81-1.17],0.7650574325578332
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22927,422,0.94 [0.87-1.01],0.0911781984746484
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Cerebral cysts,23720,172,1.03 [0.93-1.14],0.5413352597842225
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23960,199,0.95 [0.83-1.08],0.4256941792767575
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23905,21,0.56 [0.26-1.20],0.1371295656199522
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,24024,48,1.09 [0.90-1.32],0.3868847319091987
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23598,50,1.02 [0.83-1.26],0.8246700980389129
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Epilepsy,22679,227,0.91 [0.81-1.03],0.1247573297028957
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23611,1159,1.01 [0.96-1.05],0.8122141292446234
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,24007,163,0.97 [0.83-1.12],0.652522209747362
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23597,1448,1.00 [0.96-1.04],0.9248729021212596
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23713,46,0.82 [0.60-1.12],0.2135386548289006
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Hemiplegia,23907,146,0.96 [0.82-1.12],0.6119765079286064
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Hydrocephalus,23591,43,1.14 [0.94-1.38],0.1840369078867746
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,24015,60,1.10 [0.94-1.28],0.2504967273172419
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22572,67,0.92 [0.78-1.07],0.2699208084541608
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22574,69,1.15 [1.00-1.33],0.0524566034054821
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Memory loss,23903,67,1.03 [0.86-1.24],0.7351779728694563
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Migraine,22818,366,1.03 [0.98-1.09],0.250794161178084
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23960,331,1.04 [0.98-1.11],0.1709004830756296
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Motor neuron disease,17456,89,0.97 [0.80-1.17],0.7632343105487888
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23849,134,1.01 [0.91-1.11],0.8932619196227944
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23502,997,0.99 [0.95-1.03],0.6478019355592344
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Neurological diseases,22766,2658,1.00 [0.97-1.02],0.8257223684080482
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23951,67,0.84 [0.62-1.14],0.2651665616847939
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22848,343,1.03 [0.96-1.11],0.4096317056967394
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23974,203,1.01 [0.90-1.14],0.8274571462114122
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,20042,282,0.99 [0.91-1.07],0.763276767968645
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23600,52,0.96 [0.76-1.21],0.7114432700293887
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23652,104,1.08 [0.94-1.23],0.2716635257936511
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23914,70,1.06 [0.89-1.25],0.5323195178862821
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22589,84,1.00 [0.86-1.18],0.963814360336532
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other headache syndromes,22508,56,1.03 [0.88-1.21],0.7209242369444642
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other neurological diseases,23932,384,1.03 [0.96-1.10],0.3913351326665633
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other sleep disorders,22961,509,0.99 [0.92-1.07],0.8584202130657215
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Parkinson's disease,24022,74,1.01 [0.79-1.31],0.9095013838777436
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23603,55,0.98 [0.84-1.14],0.7749472729037056
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Restless leg syndrome,24034,32,1.13 [0.93-1.36],0.219711880768386
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Sleep apnoea,23818,443,1.02 [0.94-1.10],0.7004259720326955
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23803,32,1.10 [0.85-1.43],0.472532187305076
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,24021,114,0.96 [0.82-1.13],0.6520766309011616
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22532,27,1.08 [0.88-1.33],0.4366341242478094
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24035,65,1.03 [0.86-1.24],0.731335263670584
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23924,17,1.04 [0.60-1.78],0.8958767757470371
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23614,36,1.10 [0.87-1.38],0.4225695421855767
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23717,190,0.82 [0.68-0.99],0.0366551003973282
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23960,170,0.99 [0.85-1.14],0.8528400713487512
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23379,34,0.71 [0.44-1.17],0.1808218331728659
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23409,64,1.13 [0.98-1.29],0.0903620054985865
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23951,29,0.82 [0.57-1.18],0.2841931755473383
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23864,59,1.00 [0.75-1.33],0.9913759299620564
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1475,35,1.08 [0.82-1.42],0.6041488949829211
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1745,72,1.10 [0.90-1.33],0.3434255610050368
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23652,74,0.87 [0.67-1.12],0.2723847444761715
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23930,546,0.92 [0.84-1.00],0.054559937064443
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23764,419,1.01 [0.93-1.08],0.8892634148474547
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23466,121,0.91 [0.78-1.05],0.1957878556688519
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23955,428,0.87 [0.79-0.97],0.0108623828103752
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,24028,50,0.95 [0.74-1.22],0.6988347957705825
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23886,359,0.86 [0.77-0.97],0.0162177145736104
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23999,194,0.84 [0.70-1.01],0.0652451823095041
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23979,120,0.95 [0.81-1.12],0.5736070905034012
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23360,15,0.66 [0.26-1.68],0.3850433913596193
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23371,26,0.66 [0.33-1.33],0.2480665287305619
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23375,30,0.75 [0.48-1.18],0.2139101938936475
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23993,337,0.96 [0.87-1.07],0.5009141919445794
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23737,81,0.89 [0.70-1.14],0.3722323129829354
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23548,21,1.13 [0.86-1.48],0.3762308938492118
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23867,62,0.60 [0.38-0.96],0.0315622380156009
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23939,134,0.91 [0.75-1.10],0.3318230466553502
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23674,147,0.89 [0.75-1.05],0.1716548173088415
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23929,70,0.96 [0.79-1.18],0.6979949834327218
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23878,222,0.97 [0.85-1.11],0.6670211901482608
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23675,97,1.01 [0.88-1.16],0.922488052376975
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23417,952,0.94 [0.88-1.01],0.0723662403755194
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23917,112,0.84 [0.66-1.07],0.1622545060021681
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,24014,101,0.97 [0.83-1.14],0.7067014872278441
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23579,234,1.01 [0.90-1.13],0.8991635519730217
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23840,35,0.61 [0.32-1.16],0.1313109302171835
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,24012,34,0.84 [0.56-1.26],0.3985353251581899
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23381,36,1.12 [0.92-1.37],0.2636842400711152
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23448,103,0.96 [0.81-1.15],0.688027850420649
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23441,57,0.69 [0.44-1.08],0.1079010609895166
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23578,51,0.99 [0.81-1.22],0.9345217208704814
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23431,47,0.91 [0.70-1.19],0.4945010293504921
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23701,45,0.78 [0.54-1.14],0.2004196843757926
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23736,80,1.04 [0.85-1.27],0.6833337312359336
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23420,75,1.11 [0.95-1.30],0.1858624839264274
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23492,108,0.86 [0.71-1.04],0.1300312414162296
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23413,29,1.18 [0.90-1.56],0.2333189744040536
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23189,724,0.85 [0.77-0.93],0.0006867509817831
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23388,43,1.02 [0.83-1.24],0.8817077881049779
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23849,271,0.98 [0.89-1.08],0.7004498366126739
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23610,32,1.13 [0.86-1.50],0.3749377633055852
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23685,107,1.08 [0.95-1.23],0.2240967697731616
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23855,55,0.96 [0.79-1.15],0.6403022088009405
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23995,82,1.12 [0.99-1.26],0.0661829179882355
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23924,123,0.96 [0.85-1.10],0.5773102449560776
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23851,51,0.99 [0.80-1.22],0.9251567198536168
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23849,49,1.07 [0.90-1.27],0.4327396910203347
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23953,476,0.93 [0.86-1.02],0.1339762771594034
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23770,293,0.88 [0.77-1.00],0.0495365689090753
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23563,86,1.09 [0.93-1.28],0.2742652889384838
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23546,69,0.82 [0.62-1.09],0.1641466028350094
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23776,67,1.07 [0.94-1.23],0.3008036388857965
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23918,209,1.09 [1.01-1.17],0.0261298930204959
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23764,55,1.11 [0.96-1.29],0.1631177672207283
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,All influenza,22886,70,1.11 [0.95-1.28],0.1803523660028626
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22885,69,1.12 [0.97-1.30],0.1342319521106031
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),17753,115,1.08 [0.98-1.21],0.1328626746667341
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23915,278,0.98 [0.90-1.06],0.5855263876326269
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",19054,1547,1.01 [0.97-1.04],0.7634525428906487
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",19155,1517,1.00 [0.97-1.04],0.960212113564134
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23783,88,1.15 [1.01-1.30],0.0279544392026203
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22868,52,1.11 [0.94-1.32],0.2246647842800589
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Bronchiectasis,21352,152,1.03 [0.91-1.17],0.644868293733121
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",21235,35,1.16 [0.94-1.42],0.1690993904554632
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23263,2063,1.01 [0.98-1.05],0.356853463983324
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22737,60,1.11 [0.95-1.31],0.2002184467228606
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22821,144,0.97 [0.85-1.10],0.5923493014957916
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23944,636,1.01 [0.94-1.08],0.8282804302424729
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22794,117,1.01 [0.87-1.17],0.9131158109922902
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22342,3726,1.02 [1.00-1.05],0.0325497963761119
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23011,334,1.03 [0.95-1.11],0.4765100192153159
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Early onset COPD,23762,454,1.01 [0.94-1.09],0.736320037628795
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Emphysema,21364,164,0.95 [0.81-1.11],0.5183776100133288
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22912,99,1.16 [1.03-1.31],0.0119144501677696
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23873,1057,1.04 [0.99-1.09],0.1138396229926117
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22934,121,1.13 [1.01-1.25],0.0330710445938081
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Later onset COPD,22749,182,0.84 [0.63-1.11],0.2097664572669544
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,24030,134,0.90 [0.75-1.09],0.2897935827843787
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Nasal polyp,22783,106,0.93 [0.77-1.12],0.4302659880565841
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23844,557,1.02 [0.96-1.08],0.5382405311752
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23881,1101,1.02 [0.97-1.07],0.4853364249290148
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23462,785,1.01 [0.96-1.06],0.6412460983072186
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other pleural conditions,22812,32,0.84 [0.57-1.26],0.4016418574869416
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23979,178,1.14 [1.05-1.24],0.0024927497017262
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23966,750,1.01 [0.95-1.07],0.6737169203718434
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pleural effusion,23307,527,1.04 [0.97-1.11],0.3217862175193393
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pleural plaque,22829,49,1.05 [0.75-1.46],0.789848699169168
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23688,872,1.03 [0.98-1.09],0.246248135783109
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,24012,116,0.83 [0.66-1.05],0.1198996164927536
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pneumothorax,22836,56,1.01 [0.80-1.26],0.9540968309454811
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pollen allergy,24009,241,0.99 [0.90-1.08],0.7807135551695636
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pulmonary oedema,23836,35,1.25 [1.05-1.50],0.0128193499985473
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,17669,31,0.87 [0.58-1.31],0.5067884614893329
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23824,537,1.02 [0.96-1.09],0.4746493183886692
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22955,278,0.98 [0.90-1.06],0.5901560192553297
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Viral pneumonia,22981,165,1.02 [0.90-1.15],0.7811501678350701
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23800,141,1.01 [0.89-1.16],0.8472578325819506
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13822,86,1.05 [0.91-1.22],0.4723073588414579
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18373,54,1.04 [0.85-1.28],0.6877563129000431
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute appendicitis,23860,132,0.97 [0.86-1.08],0.5414686321114045
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute gastritis,19185,58,1.05 [0.88-1.25],0.5915674740120451
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute pancreatitis,22617,148,0.94 [0.81-1.10],0.4651081283831068
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute peritonitis,23632,60,1.06 [0.90-1.24],0.5037070640266554
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23356,77,0.84 [0.63-1.13],0.2530334982826701
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Barrett oesophagus,19443,316,0.92 [0.82-1.02],0.117298468852027
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22520,51,0.90 [0.66-1.23],0.524006003701301
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23681,51,0.90 [0.66-1.23],0.5205457203047299
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Cholecystitis,22626,157,1.11 [0.99-1.23],0.0624117544566686
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Cholelithiasis,23295,826,1.00 [0.96-1.05],0.8518912248210074
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Chronic gastritis,19347,220,0.97 [0.87-1.08],0.5870277456224309
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22507,38,0.92 [0.69-1.23],0.5902892553437615
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23905,76,1.14 [0.96-1.34],0.12799861605836
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Coeliac disease,22791,100,0.98 [0.85-1.12],0.7479700007920533
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Collagenous colitis,22663,49,1.08 [0.90-1.28],0.4101597701050832
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23868,180,0.99 [0.88-1.11],0.8618105507191033
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Constipation,23843,1018,0.99 [0.94-1.03],0.5558600604394717
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Crohn disease,22697,83,1.00 [0.86-1.16],0.9917291180704564
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23730,55,0.96 [0.76-1.21],0.7244105492345303
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22691,77,0.98 [0.84-1.15],0.8131174341919687
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Dental caries,23303,226,1.04 [0.96-1.13],0.323592649960616
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22190,1573,1.03 [0.99-1.06],0.1528135771821248
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of appendix,23897,169,0.97 [0.88-1.07],0.5859653675478234
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of liver,23931,652,0.99 [0.93-1.05],0.8095116791432889
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22499,3372,0.99 [0.96-1.01],0.2611580445340579
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23610,533,1.03 [0.97-1.09],0.3426256226805222
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23964,392,1.07 [1.01-1.14],0.0177978480870214
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23194,117,1.00 [0.87-1.14],0.9829707862707888
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,23055,61,0.96 [0.79-1.16],0.6567286067299332
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23790,1099,1.00 [0.96-1.04],0.9656897111277232
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of tongue,23057,106,0.94 [0.80-1.10],0.4393021100776679
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23585,1116,1.00 [0.96-1.04],0.874748473024342
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20454,2135,1.00 [0.97-1.04],0.8152856930324186
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Duodenal ulcer,19254,127,1.11 [0.97-1.26],0.1315501235700044
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23970,99,1.08 [0.92-1.27],0.3572550143079653
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23920,72,1.12 [1.01-1.25],0.0310062004662211
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23373,94,1.10 [0.94-1.28],0.2434664811656357
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18475,156,0.94 [0.82-1.07],0.3265285972551039
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Functional dyspepsia,19581,454,1.01 [0.95-1.08],0.6969673739510994
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastric ulcer,19380,253,0.97 [0.87-1.07],0.5147826784003979
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21093,1966,0.99 [0.96-1.02],0.6342005722905235
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19492,365,1.01 [0.92-1.09],0.9060457839635712
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19545,6957,1.00 [0.98-1.01],0.7561149179739155
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,GI-bleeding,23568,877,0.97 [0.92-1.03],0.3017260889005557
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23137,60,0.84 [0.64-1.10],0.2010397748209862
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,19114,1111,0.99 [0.95-1.03],0.6723724809367436
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23325,46,0.56 [0.33-0.97],0.0376401210591704
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Hernia,22993,2376,1.03 [1.00-1.06],0.039689696273601
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Impacted teeth,23930,67,1.10 [0.98-1.23],0.1198868808190241
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Impaction of intestines,18351,32,0.96 [0.75-1.24],0.7773540125964071
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Inguinal hernia,21214,597,1.07 [0.96-1.19],0.2250790630020018
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",20688,71,0.98 [0.67-1.44],0.9108739818783872
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,18383,64,0.94 [0.76-1.16],0.5844040684365565
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22812,121,1.08 [0.97-1.20],0.1423689390712717
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18825,506,0.95 [0.90-1.01],0.116317898360987
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24010,342,0.98 [0.89-1.06],0.5788137717065549
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23225,611,0.97 [0.92-1.03],0.3810347658839507
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23382,768,0.97 [0.92-1.02],0.2735541934756128
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19248,121,1.12 [0.98-1.27],0.097454497037211
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Oesophagitis,19552,425,1.04 [0.96-1.11],0.3421068512543013
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23995,116,0.97 [0.85-1.12],0.7222396784114444
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20660,43,1.10 [0.91-1.33],0.322616967287415
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19452,1133,0.96 [0.92-1.01],0.1229576196259162
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22641,172,0.97 [0.85-1.11],0.6506533063152178
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22610,141,1.01 [0.90-1.13],0.9293884242009662
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of intestine,19647,1328,0.96 [0.92-1.01],0.0925602272631748
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of intestines,22575,4256,0.98 [0.96-1.00],0.0634992184500316
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23055,169,0.93 [0.82-1.06],0.2713431168791728
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of liver,23804,525,0.98 [0.91-1.05],0.5868946774450341
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19607,480,0.97 [0.90-1.04],0.4018672236705551
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22541,72,0.96 [0.77-1.18],0.6847807153294544
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23916,344,1.07 [1.01-1.14],0.0276947792653621
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19800,673,0.96 [0.90-1.02],0.1881185617785313
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23582,891,0.98 [0.93-1.03],0.3765197442669419
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23227,150,0.87 [0.74-1.02],0.0800980705110964
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19381,1062,0.98 [0.94-1.03],0.4633498768670988
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),20667,1540,1.00 [0.96-1.04],0.9432799100399004
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23351,72,1.05 [0.90-1.22],0.5479459840865929
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23283,669,0.98 [0.92-1.03],0.4466217711459219
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18530,211,0.98 [0.88-1.09],0.6756886881366412
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23905,85,1.11 [1.01-1.23],0.0374375260621595
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18630,311,0.96 [0.88-1.04],0.3155205907613335
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22814,123,1.10 [0.98-1.23],0.11415929224558
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,24025,53,0.86 [0.68-1.10],0.2319418735084186
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23088,109,0.93 [0.80-1.08],0.326916388729667
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Toxic colitis,22636,22,0.97 [0.71-1.34],0.8689246295317041
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19295,168,0.89 [0.75-1.05],0.1736256252381951
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22744,130,0.95 [0.84-1.08],0.4313993827502805
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22727,113,0.98 [0.87-1.12],0.7849514309505106
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Umbilical hernia,20853,236,1.04 [0.94-1.14],0.4652329344508721
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,18410,91,0.99 [0.84-1.16],0.8783246269119037
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Ventral hernia,20821,204,1.05 [0.96-1.16],0.2842471013595134
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Volvulus,18377,58,0.88 [0.70-1.11],0.279481957573238
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23996,135,1.02 [0.89-1.17],0.7913998653207942
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23803,73,1.09 [0.95-1.26],0.2034182912154534
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22733,126,0.99 [0.89-1.11],0.9165053561805466
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23472,489,0.97 [0.90-1.05],0.457226940396792
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23160,177,0.96 [0.85-1.09],0.5341197787877943
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22758,151,0.97 [0.83-1.13],0.7097612331779306
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23805,202,1.04 [0.96-1.14],0.3331459892837283
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23945,342,1.00 [0.93-1.08],0.899023784007989
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23642,39,1.09 [0.92-1.30],0.314747077428094
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22748,2245,1.00 [0.97-1.03],0.8283867481043274
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23633,374,0.98 [0.92-1.05],0.6159834966409578
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23523,264,0.97 [0.89-1.05],0.4097371701848189
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23681,698,0.96 [0.90-1.02],0.1960631671204017
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",24024,41,0.82 [0.62-1.10],0.1925276511104604
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22660,53,1.04 [0.88-1.22],0.6695437438411727
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23295,36,1.04 [0.83-1.30],0.7555492208699421
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23799,196,1.05 [0.96-1.15],0.294139963108637
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22871,264,1.03 [0.95-1.12],0.4878090558775702
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22641,34,1.02 [0.78-1.32],0.9040085240944644
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23959,64,1.04 [0.86-1.25],0.6942998964477181
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23100,117,0.89 [0.74-1.06],0.1848443548498384
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23863,133,1.01 [0.88-1.16],0.9225411276132442
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23627,24,1.17 [0.88-1.55],0.2833810170014817
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22653,46,1.13 [0.95-1.34],0.1800734129981107
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23583,976,1.02 [0.98-1.07],0.2827002485408255
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22899,292,1.04 [0.97-1.13],0.2750074939337083
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22645,38,1.07 [0.86-1.33],0.5487886570548637
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23964,234,1.02 [0.93-1.12],0.6871636222711248
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23658,55,0.84 [0.65-1.10],0.2106170075400798
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23921,191,1.05 [0.95-1.16],0.3241522808705033
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24010,149,1.03 [0.91-1.17],0.6605848532069517
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22713,106,0.96 [0.85-1.09],0.5329513431919615
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22774,167,1.01 [0.90-1.14],0.8774893963852967
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24005,144,1.03 [0.90-1.18],0.644619544967491
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22723,116,1.18 [1.05-1.32],0.0062113932473439
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,24003,108,1.00 [0.87-1.16],0.9748310145903828
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,21054,115,1.03 [0.92-1.15],0.6355827382566773
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22404,4062,0.97 [0.95-1.00],0.0296646422279972
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21213,2871,0.96 [0.93-0.99],0.0128277946694692
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,21025,86,0.89 [0.74-1.07],0.2238209251537178
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21533,139,1.01 [0.90-1.13],0.8243214935339161
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21535,141,0.82 [0.70-0.97],0.0192991390735255
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23832,105,0.96 [0.84-1.10],0.5854339021044892
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21437,43,0.98 [0.72-1.35],0.9073165937647648
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19011,669,0.99 [0.93-1.05],0.6382224209756739
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23982,113,1.02 [0.87-1.20],0.832162884783818
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21643,249,0.95 [0.85-1.05],0.3234105020918374
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20984,5450,0.98 [0.96-1.00],0.0421677099960557
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22810,97,0.98 [0.83-1.14],0.7737776690240157
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,21041,102,0.90 [0.75-1.08],0.2639348418945069
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21484,545,0.99 [0.93-1.05],0.6713386358042046
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23238,1844,1.00 [0.97-1.03],0.9547387807395008
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21142,203,0.80 [0.67-0.95],0.0105872224512091
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21199,260,0.98 [0.92-1.05],0.6124209616464164
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,21071,132,1.07 [0.97-1.18],0.1653053936488725
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23558,32,1.02 [0.81-1.29],0.8788127440646062
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19477,1135,0.97 [0.92-1.02],0.2193023381758229
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18684,342,1.15 [1.04-1.27],0.0082438408090798
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23987,332,1.17 [1.06-1.30],0.0027150955100531
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18410,68,1.07 [0.93-1.23],0.3511856696231518
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18650,308,1.00 [0.93-1.07],0.9898174687687564
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21227,288,1.04 [0.96-1.12],0.3504534858545328
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19009,667,0.98 [0.92-1.04],0.519703566623763
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,21418,24,1.03 [0.80-1.33],0.824628905961577
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21890,496,1.00 [0.94-1.06],0.9482566664317772
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21647,253,1.01 [0.93-1.10],0.8200052190347822
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18961,619,0.99 [0.93-1.05],0.6981070090585639
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,21006,67,1.02 [0.88-1.19],0.7465206572826284
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20994,55,0.78 [0.59-1.05],0.0972519353274907
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22766,53,0.87 [0.64-1.18],0.3698306002025791
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23744,1031,0.95 [0.91-1.00],0.0399968327954385
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23293,580,0.93 [0.87-1.00],0.0473711730928739
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23929,307,0.98 [0.90-1.07],0.6430980439533007
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19893,1551,0.95 [0.91-0.99],0.0230955216310746
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18410,68,0.90 [0.73-1.10],0.2887304638151961
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,21008,69,1.07 [0.93-1.23],0.331331816843577
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18367,25,0.88 [0.56-1.39],0.5933013804584062
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18445,103,0.81 [0.66-0.99],0.0419033343833716
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22922,209,0.97 [0.88-1.07],0.5718979919379232
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22937,224,1.00 [0.92-1.10],0.9486733781359828
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23999,74,0.89 [0.71-1.11],0.3000284677135509
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22780,1386,0.99 [0.95-1.03],0.6003623093740976
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,21046,107,0.85 [0.72-1.00],0.0469318278054211
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18454,112,1.05 [0.93-1.18],0.4119984007739281
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21951,557,0.99 [0.93-1.05],0.7603147695760972
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20143,1801,0.97 [0.94-1.00],0.0820535869257035
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23577,51,0.94 [0.76-1.17],0.6002596044784478
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,24011,68,1.10 [0.96-1.27],0.1662085669982517
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,21009,70,0.91 [0.73-1.13],0.3995407602310906
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21911,972,0.99 [0.95-1.03],0.6271350844011552
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20999,60,0.91 [0.72-1.14],0.3983287204236783
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19337,995,0.99 [0.94-1.04],0.6016116096469817
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22808,95,0.99 [0.86-1.13],0.8426177924153628
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20998,59,0.71 [0.50-1.00],0.0484666318736092
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,21494,100,0.91 [0.75-1.10],0.314348630267608
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21287,348,1.03 [0.95-1.11],0.5109736158629765
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23715,189,0.90 [0.79-1.02],0.0855086755581108
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21816,422,0.99 [0.92-1.06],0.781520934133138
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23938,292,1.00 [0.92-1.08],0.9635492793100416
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,24018,34,1.11 [0.89-1.38],0.3427358234921074
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,21125,186,0.95 [0.84-1.06],0.3515770458784683
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19257,544,0.92 [0.86-0.99],0.0182385393615939
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21378,439,0.99 [0.93-1.06],0.8672333808218571
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],21090,151,0.77 [0.60-0.97],0.0302259393530401
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18375,33,0.88 [0.66-1.18],0.3943552985312166
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19903,1561,0.99 [0.95-1.03],0.55675834367346
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18739,397,0.97 [0.89-1.05],0.409526358351128
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23604,78,0.93 [0.72-1.20],0.5599352456781206
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23969,44,0.93 [0.71-1.22],0.5897151453969125
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22638,26,1.24 [0.98-1.56],0.069416708416404
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18412,70,1.09 [0.95-1.26],0.215091242776345
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,21474,80,1.02 [0.87-1.20],0.7864741855465371
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18652,310,0.97 [0.89-1.05],0.459566888410168
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21179,240,0.95 [0.85-1.07],0.4143075677812864
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21586,192,1.03 [0.94-1.13],0.5655219639132566
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,21485,91,0.94 [0.80-1.11],0.469299201470728
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20308,44,0.90 [0.70-1.16],0.4079888719355544
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",24021,37,1.10 [0.88-1.38],0.3917759358805227
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21465,526,1.00 [0.94-1.06],0.9353556874200948
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23603,77,0.88 [0.73-1.05],0.1552510916156212
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,23086,2147,0.98 [0.95-1.01],0.2273885573935264
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",21039,100,0.93 [0.80-1.10],0.4060961995386517
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21712,318,1.01 [0.92-1.10],0.8718207053968404
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22790,164,0.97 [0.86-1.10],0.6420520173880505
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,21526,132,0.93 [0.78-1.10],0.3775711960123865
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22340,946,1.03 [0.98-1.07],0.2975764928201845
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,22014,620,1.01 [0.96-1.08],0.640311761987668
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20978,39,1.16 [0.99-1.36],0.0733156443929449
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23669,143,1.04 [0.95-1.13],0.4208479045026962
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,21078,139,0.99 [0.88-1.12],0.929115596085908
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20992,53,0.88 [0.71-1.10],0.2718682436518397
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18375,33,1.03 [0.80-1.31],0.840988523682169
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23576,749,1.02 [0.96-1.09],0.4439292963950507
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9759,63,1.01 [0.91-1.12],0.8378274396661249
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,12983,72,1.15 [1.05-1.26],0.0022850273332613
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23778,272,1.00 [0.90-1.11],0.9625191884297556
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23560,54,0.68 [0.42-1.09],0.1116501819841853
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23388,561,1.11 [1.05-1.18],0.0004468791354977
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23875,19,1.25 [0.95-1.64],0.1160221929967623
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23881,160,1.04 [0.91-1.19],0.541028572672134
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Cystitis,22086,136,1.04 [0.93-1.16],0.4846270163190196
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Dialysis,22869,42,1.26 [1.07-1.49],0.0050928114856629
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10387,983,1.05 [0.93-1.18],0.4579843698027696
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13085,174,1.07 [1.00-1.14],0.0605811928622131
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9810,114,1.00 [0.93-1.08],0.9142015737397926
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10027,331,1.07 [1.03-1.11],0.0005779223390972
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,10067,371,1.00 [0.95-1.06],0.9677491164857462
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20249,3687,1.05 [1.03-1.07],2.6602252064029693e-06
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23914,58,1.02 [0.84-1.23],0.8411063872088546
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Hydrocele,9473,69,1.58 [1.07-2.33],0.0213671529390407
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22751,195,0.99 [0.89-1.12],0.92971899684504
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,10059,655,1.11 [0.96-1.29],0.1589348010708763
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12964,207,1.00 [0.94-1.07],0.8842290014944427
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9496,92,1.15 [0.79-1.68],0.4538201031305254
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Irregular menses,12983,106,1.05 [0.97-1.12],0.2144445078263051
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,9954,258,1.08 [1.04-1.13],0.0002108847699277
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,22004,54,0.99 [0.79-1.23],0.9185439983915804
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10916,1220,1.01 [0.99-1.04],0.3160260064927958
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,9451,47,1.03 [0.59-1.81],0.905596643035476
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9783,87,0.99 [0.90-1.09],0.810371836684954
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",24025,35,1.22 [1.02-1.46],0.0299208898736858
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",24030,42,1.05 [0.86-1.28],0.6248583607687828
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23270,1320,1.03 [0.99-1.07],0.1039664035243718
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22361,411,0.89 [0.79-0.99],0.0303917533594143
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12966,55,0.86 [0.72-1.04],0.1138897088113947
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23988,267,1.09 [1.00-1.19],0.0557970567190562
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9540,136,1.04 [0.74-1.45],0.8189091116861742
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9507,103,0.87 [0.59-1.29],0.486168369055878
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,9466,62,1.26 [0.80-1.98],0.3132301415649881
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,24001,50,0.90 [0.70-1.14],0.3720818281530444
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22924,974,1.04 [1.00-1.09],0.04748269191156
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12864,107,1.05 [0.97-1.14],0.2601545505449621
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9765,69,0.99 [0.87-1.12],0.8841772419245155
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9900,204,1.03 [0.96-1.09],0.4376620205041964
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9750,54,0.84 [0.69-1.03],0.0945308799604118
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9791,95,1.00 [0.91-1.12],0.92828983879088
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22781,225,1.03 [0.94-1.13],0.5253127571077215
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23813,92,1.14 [1.00-1.30],0.0558574400559436
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9845,149,0.94 [0.86-1.02],0.1366187727740345
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9764,68,1.03 [0.93-1.13],0.6004505502639949
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10060,364,1.01 [0.96-1.06],0.6426222983477667
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9753,57,1.09 [0.95-1.24],0.2094547699877403
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,10019,323,1.01 [0.95-1.07],0.7432422790729609
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23896,40,0.96 [0.72-1.28],0.7786229255474814
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9499,95,0.93 [0.62-1.39],0.7164131841983796
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23872,1316,1.05 [1.00-1.09],0.0350527783657632
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22680,124,0.98 [0.87-1.10],0.740763252915638
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22886,59,1.06 [0.87-1.29],0.5553769264211756
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23567,61,1.00 [0.82-1.23],0.9701958250368192
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,22095,145,0.95 [0.81-1.12],0.5486361868857624
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23836,330,1.00 [0.91-1.10],0.9684069751869486
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9781,85,0.97 [0.88-1.08],0.6341239358280385
